We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$97.6B
AUM Growth
+$13.8B
Cap. Flow
+$6.88B
Cap. Flow %
7.05%
Top 10 Hldgs %
24.85%
Holding
8,027
New
582
Increased
3,285
Reduced
3,349
Closed
442

Sector Composition

Rank Sector Weight
1 Healthcare 5.21%
2 Financials 5.16%
3 Technology 4.66%
4 Consumer Discretionary 3.61%
5 Energy 3.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DYN.WS
7351
DELISTED
Dynegy Inc,
DYN.WS
$1K ﹤0.01%
1,435
+182
+15% +$230
SVA
7352
DELISTED
Sinovac Biotech, Ltd
SVA
$1K ﹤0.01%
+153
New +$922
CWBC
7353
DELISTED
Community West BanCshares
CWBC
$1K ﹤0.01%
+100
New +$584
PTM
7354
DELISTED
E-TRACS UBS Long Platinum ETN
PTM
$1K ﹤0.01%
46
PACD
7355
DELISTED
Pacific Drilling S A
PACD
$1K ﹤0.01%
+7
New +$798
DDC
7356
DELISTED
Dominion Diamond Corporation
DDC
$1K ﹤0.01%
100
-7,479
-99% -$100K
AB icon
7357
AllianceBernstein
AB
$3.43B
-51
Closed -$1K
AAXJ icon
7358
CALL
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.69B
-842,000
Closed -$48.8M
ABUS icon
7359
Arbutus Biopharma
ABUS
$847M
-400
Closed -$2K
ALNT icon
7360
Allient
ALNT
$1.51B
-1,050
Closed -$6K
ALT icon
7361
Altimmune
ALT
$550M
0
ANIK icon
7362
CALL
Anika Therapeutics
ANIK
$249M
-120,000
Closed -$2.76M
AROC icon
7363
CALL
Archrock
AROC
$6.29B
-3,800
Closed -$103K
ARTNA icon
7364
Artesian Resources
ARTNA
$355M
-76
Closed -$2K
EFOR
7365
Everforth Inc
EFOR
$1.14B
-24,820
Closed -$819K
ASMB icon
7366
Assembly Biosciences
ASMB
$501M
-94
Closed -$17.1K
ASRV icon
7367
AmeriServ Financial
ASRV
$76.8M
-100
Closed
ATLC icon
7368
Atlanticus Holdings
ATLC
$1.62B
-1
Closed
ATR icon
7369
PUT
AptarGroup
ATR
$8.52B
-1,000
Closed -$60K
AXS icon
7370
CALL
AXIS Capital
AXS
$7.73B
-200
Closed -$9K
BAK icon
7371
Braskem
BAK
$928M
-83,814
Closed -$1.46M
BANX
7372
ArrowMark Financial
BANX
$197M
$0 ﹤0.01%
+2
New +$50
BBDC icon
7373
Barings BDC
BBDC
$862M
-12,839
Closed -$372K
BCS icon
7374
Barclays
BCS
$92.7B
$0 ﹤0.01%
2
BF.B icon
7375
CALL
Brown-Forman Class B
BF.B
$13.2B
-4,063
Closed -$88K

Similar funds

Barclays's Q4 2013 Portfolio in Review

As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Barclays deployed $6.88B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.

By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.

  • Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
  • Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
  • Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
  • Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
  • Barclays opened 582 new positions and closed 442 in Q4 2013.
  • Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.

Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.